Labopharm Inc. - Product Pipeline Review - Q1 2011
Summary
Global Market Direct’s pharmaceuticals report, “Labopharm Inc. - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
Summary
Global Market Direct’s pharmaceuticals report, “Labopharm Inc. - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Labopharm Inc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Labopharm Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Labopharm Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Labopharm Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
- Evaluate Labopharm Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Labopharm Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Labopharm Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Labopharm Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Labopharm Inc. and identify potential opportunities in those areas.
Table of Contents
List of Tables
List of Figures
Labopharm Inc. Snapshot
Labopharm Inc. Overview
Key Information
Key Facts
Labopharm Inc. – Research and Development Overview
Key Therapeutic Areas
Labopharm Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Labopharm Inc. – Pipeline Products Glance
Labopharm Inc. – Late Stage Pipeline
Registration Filed Products/Combination Treatment Modalities
Labopharm Inc.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Labopharm Inc. – Drug Profiles
DDS-06C
Product Description
Mechanism of Action
R&D Progress
DDS-06B
Product Description
R&D Progress
DDS-04F
Product Description
Mechanism of Action
R&D Progress
DDS-06A
Product Description
Mechanism of Action
R&D Progress
DDS-06E
Product Description
Mechanism of Action
R&D Progress
DDS-07L
Product Description
Mechanism of Action
R&D Progress
DDS-07U
Product Description
Mechanism of Action
R&D Progress
Labopharm Inc. – Pipeline Analysis
Labopharm Inc. – Pipeline Analysis
Labopharm Inc. – Pipeline Products by Therapeutic Class
Labopharm Inc. - Pipeline Products By Target
Labopharm Inc. – Pipeline Products by Route of Administration
Labopharm Inc. – Company Statement
Labopharm Inc. – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Nov 12, 2010: Labopharm Receives Notice Of ANDA Submission With Paragraph IV Certification For Generic Of OLEPTRO
Oct 14, 2010: Labopharm Receives FDA Acceptance For Response Of Trazodone Formulation As Complete
Oct 13, 2010: Labopharm Receives Approval For Twice-Daily Tramadol-Acetaminophen In Europe
Aug 10, 2010: Labopharm announces U.S. launch of Oleptro for treatment of major depressive disorder in adults
Apr 29, 2010: Labopharm and Angelini to Establish Joint Venture to Commercialize Oleptro in the United States
Feb 03, 2010: Labopharm Receives FDA Approval For Oleptro
Dec 21, 2009: Labopharm Completes Distribution And Supply Agreement With MSD For Tradorec XL In UK
Dec 21, 2009: Labopharm completes distribution and supply agreement with MSD for Tradorec XL (once-daily tramadol) in the United Kingdom
Dec 17, 2009: Labopharm Initiates Regulatory Approval Of Tramadol-Acetaminophen In Europe
Nov 11, 2009: Labopharm's Novel Trazodone Formulation Subject Of Publication In Peer-Reviewed Medical Journal
Financial Deals Landscape
Labopharm Inc., Deals Volume Summary, 2004 to YTD 2011
Labopharm Inc., Deals Summary By Region, 2004 to YTD 2011
Labopharm Inc., Deals Summary, 2004 to YTD 2011
Labopharm Inc. Detailed Deal Summary
Asset Purchase
Labopharm Reacquires Marketing Rights To Tramadol XL From Recordati
Equity Offering
Labopharm Completes First Tranche Of Private Placement For $0.94 Million
Labopharm Completes Public Offering Of $101.2 Million
Labopharm Enters Into Distribution And Supply Agreement With Merck
Labopharm Enters Into Distribution Agreement With Grunenthal
Labopharm Enters Into Licensing Agreement With GlaxoSmithKline
Debiopharm Enters Into Research Agreement With Labopharm
Licensing Agreements
Labopharm Enters Into A License And Distribution Agreement With iNova
Labopharm Enters Into A License And Distribution Agreement With Paladin Labs
Labopharm Enters Into A License Agreement With WhanIn Pharmaceutical
Labopharm Expands Licensing Agreement With GlaxoSmithKline
Labopharm Enters Into A License And Distribution Agreement With Grunenthal
Labopharm Enters Into License And Distribution Agreement With Grunenthal And Sanofi
Labopharm Enters Into License And Distribution Agreement With Recordati
Labopharm Enters Into A License Agreement With Ortho-McNeil
Labopharm Enters Into A License And Distribution Agreement With Purdue Pharma
Labopharm Amends License And Distribution Agreement With CSC Pharmaceuticals
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
Labopharm Inc. – Pipeline by Therapy Area and Indication, 2011
Labopharm Inc. – Pipeline by Stage of Development, 2011
Labopharm Inc. – Monotherapy Products in Pipeline, 2011
Labopharm Inc. – Filed, 2011
Labopharm Inc. - Pipeline By Therapeutic Class, 2011
Labopharm Inc. - Pipeline By Target, 2011
Labopharm Inc. – Pipeline By Route of Administration, 2011
Labopharm Inc., Subsidiaries
Labopharm Inc., Deals Summary, 2004 to YTD 2011
Labopharm Inc., Deals Summary by Region, 2004 to YTD 2011
Labopharm Inc., Deals Summary, 2004 to YTD 2011
LIST OF FIGURES
Labopharm Inc. – Pipeline by Therapy Area and Indication, 2011
Labopharm Inc. – Pipeline by Stage of Development, 2011
Labopharm Inc. – Monotherapy Products in Pipeline, 2011
Labopharm Inc. – Pipeline By Therapeutic Class, 2011
Labopharm Inc. - Pipeline By Target, 2011
Labopharm Inc. – Pipeline By Route of Administration, 2011
List of Tables
List of Figures
Labopharm Inc. Snapshot
Labopharm Inc. Overview
Key Information
Key Facts
Labopharm Inc. – Research and Development Overview
Key Therapeutic Areas
Labopharm Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Labopharm Inc. – Pipeline Products Glance
Labopharm Inc. – Late Stage Pipeline
Registration Filed Products/Combination Treatment Modalities
Labopharm Inc.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Labopharm Inc. – Drug Profiles
DDS-06C
Product Description
Mechanism of Action
R&D Progress
DDS-06B
Product Description
R&D Progress
DDS-04F
Product Description
Mechanism of Action
R&D Progress
DDS-06A
Product Description
Mechanism of Action
R&D Progress
DDS-06E
Product Description
Mechanism of Action
R&D Progress
DDS-07L
Product Description
Mechanism of Action
R&D Progress
DDS-07U
Product Description
Mechanism of Action
R&D Progress
Labopharm Inc. – Pipeline Analysis
Labopharm Inc. – Pipeline Analysis
Labopharm Inc. – Pipeline Products by Therapeutic Class
Labopharm Inc. - Pipeline Products By Target
Labopharm Inc. – Pipeline Products by Route of Administration
Labopharm Inc. – Company Statement
Labopharm Inc. – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Nov 12, 2010: Labopharm Receives Notice Of ANDA Submission With Paragraph IV Certification For Generic Of OLEPTRO
Oct 14, 2010: Labopharm Receives FDA Acceptance For Response Of Trazodone Formulation As Complete
Oct 13, 2010: Labopharm Receives Approval For Twice-Daily Tramadol-Acetaminophen In Europe
Aug 10, 2010: Labopharm announces U.S. launch of Oleptro for treatment of major depressive disorder in adults
Apr 29, 2010: Labopharm and Angelini to Establish Joint Venture to Commercialize Oleptro in the United States
Feb 03, 2010: Labopharm Receives FDA Approval For Oleptro
Dec 21, 2009: Labopharm Completes Distribution And Supply Agreement With MSD For Tradorec XL In UK
Dec 21, 2009: Labopharm completes distribution and supply agreement with MSD for Tradorec XL (once-daily tramadol) in the United Kingdom
Dec 17, 2009: Labopharm Initiates Regulatory Approval Of Tramadol-Acetaminophen In Europe
Nov 11, 2009: Labopharm's Novel Trazodone Formulation Subject Of Publication In Peer-Reviewed Medical Journal
Financial Deals Landscape
Labopharm Inc., Deals Volume Summary, 2004 to YTD 2011
Labopharm Inc., Deals Summary By Region, 2004 to YTD 2011
Labopharm Inc., Deals Summary, 2004 to YTD 2011
Labopharm Inc. Detailed Deal Summary
Asset Purchase
Labopharm Reacquires Marketing Rights To Tramadol XL From Recordati
Equity Offering
Labopharm Completes First Tranche Of Private Placement For $0.94 Million
Labopharm Completes Public Offering Of $101.2 Million
Labopharm Enters Into Distribution And Supply Agreement With Merck
Labopharm Enters Into Distribution Agreement With Grunenthal
Labopharm Enters Into Licensing Agreement With GlaxoSmithKline
Debiopharm Enters Into Research Agreement With Labopharm
Licensing Agreements
Labopharm Enters Into A License And Distribution Agreement With iNova
Labopharm Enters Into A License And Distribution Agreement With Paladin Labs
Labopharm Enters Into A License Agreement With WhanIn Pharmaceutical
Labopharm Expands Licensing Agreement With GlaxoSmithKline
Labopharm Enters Into A License And Distribution Agreement With Grunenthal
Labopharm Enters Into License And Distribution Agreement With Grunenthal And Sanofi
Labopharm Enters Into License And Distribution Agreement With Recordati
Labopharm Enters Into A License Agreement With Ortho-McNeil
Labopharm Enters Into A License And Distribution Agreement With Purdue Pharma
Labopharm Amends License And Distribution Agreement With CSC Pharmaceuticals
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
Labopharm Inc. – Pipeline by Therapy Area and Indication, 2011
Labopharm Inc. – Pipeline by Stage of Development, 2011
Labopharm Inc. – Monotherapy Products in Pipeline, 2011
Labopharm Inc. – Filed, 2011
Labopharm Inc. - Pipeline By Therapeutic Class, 2011
Labopharm Inc. - Pipeline By Target, 2011
Labopharm Inc. – Pipeline By Route of Administration, 2011
Labopharm Inc., Subsidiaries
Labopharm Inc., Deals Summary, 2004 to YTD 2011
Labopharm Inc., Deals Summary by Region, 2004 to YTD 2011
Labopharm Inc., Deals Summary, 2004 to YTD 2011
LIST OF FIGURES
Labopharm Inc. – Pipeline by Therapy Area and Indication, 2011
Labopharm Inc. – Pipeline by Stage of Development, 2011
Labopharm Inc. – Monotherapy Products in Pipeline, 2011
Labopharm Inc. – Pipeline By Therapeutic Class, 2011
Labopharm Inc. - Pipeline By Target, 2011
Labopharm Inc. – Pipeline By Route of Administration, 2011
